Over the course of three years, the AUACTC aims to develop and implement a comprehensive physician education dissemination plan. Through this physician education dissemination plan, the AUACTC aims to enhance awareness, improve trial site practices, train navigators, promote effective communication, and streamline access to clinical trials. These efforts will contribute to advancing medical research and improving patient outcomes.
The AUACTC consists of a Chair, and twelve (12) clinical trial expert physicians that are AUA members.
Industry partners will have the opportunity to sit on the AUACTC through an annual membership. Each industry partner member can secure a seat on the AUACTC for an annual membership fee of $50,000.
Those interested should contact Keith Price, Industry Relations Director, at
kprice@auanet.org. Membership commitments are due no later than 1/15/2025 for year #2/2025.
The group’s mission is to address and overcome the challenges faced by clinical trials, including resource constraints, lack of clinical trial navigators, physician unawareness of clinical trials, and reaching underrepresented patients in rural communities.
The AUACTC will focus on the following areas:
Resource Constraints: The group will discuss resource constraints faced by clinical trial sites, including financial and personnel resources. They will identify strategies to overcome these challenges and ensure adequate resources are available for conducting clinical trials.
Clinical Trial Navigators: The group will address the lack of clinical trial navigators who can guide patients through the clinical trial process. They will explore the feasibility of developing clinical trial navigator training programs to ensure patients have access to the support they need.
Physician Awareness: The group will address the lack of physician awareness of clinical trials, including identifying strategies to improve physician education and awareness of clinical trials for referrals.
Underrepresented Patients: The group will discuss the challenges faced by underrepresented patients in rural communities and identify strategies to increase their participation in clinical trials.
The AUACTC will convene three meetings annually to assess progress and plan future initiatives. In year #2 (2025), two of these gatherings will be held virtually and one will be held in person at the AUA Annual Meeting to foster continuous collaboration and communication among physician leaders and pharmaceutical members despite potential geographic and travel barriers.
Virtual meetings will facilitate efficient teamwork, while the in-person meeting at the AUA’s Annual Meeting will provide a chance for face-to-face discussions and interactions. By adhering to a consistent meeting schedule, the AUACTC can stay on track towards achieving their objectives and delivering their planned outputs. It will also allow the group to adapt their strategies as needed in response to emerging challenges and opportunities.
The AUACTC will continue to base its recommendations on a robust needs assessment. The needs assessment included 1:1 interviews with our industry partners to ensure their expertise and experience is captured. A literature review was conducted to identify research that has already been published associated with areas such as barriers to clinical trials. And finally, a survey was developed based on information gained from the interviews, literature review, and the first AUACTC meeting. This survey was sent to all AUA domestic physicians and advanced practice providers. The results of this overall needs assessment were used as the foundation to develop strategies to address the challenges faced by clinical trials. The results of the survey were available exclusively to AUACTC industry members and AUA members. In 2025, (year #2) the AUACTC will build upon the foundation laid in 2024 (year #1) by developing strategies to address identified challenges and initiating the creation of a physician education program. This program will include the development and dissemination of educational materials designed to support improved clinical practice.
AUA is making a long-term commitment to increasing awareness of, and engagement in, clinical trials. The cornerstone of the awareness initiatives will be under the umbrella of our AUANews print and digital ecosystem. AUANews, the official newsmagazine of the AUA, the most widely read urological newsletter in the United States, is a trusted resource for the most up-to-date clinical content written by urologists, for urologists.
This high-profile print placement with accompanying online content will allow you to highlight specific clinical trials in an editorial format or simply raise awareness about the importance of clinical trials and your commitment to these through a well-crafted and thoughtful advertorial piece. The AUA’s editorial staff will format your content using AUANews copyediting and composition style to make the advertorial have the look and feel of an AUANews article. It will be marked as advertorial.
Mail a complete, separate printed piece with the monthly issue of AUANews. Pricing will depend on the size and scope of the printed piece being -mailed with the issue. Our team can assist you in conceptualizing and designing the print supplement that works best for your messaging.
AUANews will introduce an Associate Editor focused on clinical trials. The new Associate Editor will be a permanent member of the AUANews Editorial Board. This Editor will work with the Editorial Board to ensure relevant clinical trial content will be included in all 24 issues of AUANews. This creates ongoing opportunities to partner and grow the awareness of clinical trials.
This content, along with the digital content we will be developing (see podcasts and webinars below), will be consolidated into a quarterly e-newsletter called “AUANews - Inside the Trials” and sent to all AUA members. Opportunities to partner on this e-newsletter include:
Banner ads on e-newsletter ($3,000 for leaderboard 728x90 ad)
Promoting your clinical trials or related editorial content within the e-newsletter ($2,500 for 150 words with link)
Retargeting opportunities (see below)
The “Inside the Trials” podcast is a clinical trial-focused series that explores the latest research and innovations in urology. Each episode will feature interviews with leading urologists, researchers, and clinical trial coordinators who provide insights into their work, the latest clinical trial designs, and their potential implications for urology patients.
The podcast will follow a conversational format with a host and guest industry speaker(s). The host will introduce the guest and their expertise, followed by a discussion of a specific clinical trial. The conversation will cover the goals of the trial, the patient population involved, the trial design and methodology, and any interesting or novel findings. The host will conclude each episode with a summary of the key takeaways from the conversation.
The podcast will cover a range of urological conditions including prostate cancer, bladder cancer, kidney stones, urinary incontinence, and more. Each episode will focus on a different clinical trial or series of trials related to the topic at hand.
The “Inside the Trials” podcast is intended for urologists, researchers, and anyone with an interest in clinical trials related to urologic conditions. It will provide a valuable resource for those seeking to stay up-to-date on the latest research and findings in the field.
The podcast will be released on a bi-monthly schedule, with each episode running approximately 15-20 minutes in length. The first season will consist of six episodes, with the potential for additional seasons based on audience feedback and interest.
The podcast will be released on the AUANews Inside Tract podcast channel and promoted through the AUA’s myriad of promotional channels, including social media, email newsletters, AUANews eTOC alerts, and other promotional outlets. The podcast will also be made available on popular podcast platforms such as Apple Podcasts, Spotify, and Google Podcasts.
$20,000 per episode
If you’re searching for a powerful method to advertise your clinical trials to a specific audience, the AUA social media promotion sponsorship can provide impactful results.
As a sponsor, you will have the chance to reach more than 124,000 followers, who are members of the American Urological Association and the urology community at large. This sponsorship presents a unique possibility to display your clinical trials to an engaged and responsive audience.
You will have the opportunity to introduce your company and share pre-screened, compelling content, videos, and photos with AUA followers through our dynamic social media platforms (Twitter, Facebook, Instagram and LinkedIn). Through this partnership, you’ll be able to reach a targeted audience of urologists, researchers, and oncologists who value immediate access to the latest advancements and updates in the field.
The Social Media package includes 3 posts/tweets on one of the following platforms (you may choose to have your three posts/tweets appear on different platforms):
Twitter: 42,499 Followers*
Facebook: 55,531 Followers*
Instagram: 14,971 Followers*
LinkedIn: 11,342 Followers*
*Social Media Stats are as of 5/9/2023
The post may be a video, graphic post, or story. The posts/tweets must appear within a 30-day period. An ideal time to consider such a campaign may be during an awareness month associated with an important clinical trial for your organization, at the launch of a recruitment campaign for your clinical trial, or as part of a campaign. Our social medial team will work with you to help craft the perfect messaging and posts. We can also customize plans to meet your specific needs.
Apart from publicizing your clinical trials, promotion on social channels can increase your company’s visibility, establish your brand as an industry leader and help generate valuable leads. With a wide array of benefits, this sponsorship is an excellent investment for companies keen on maximizing their marketing efforts, solidifying their position in the urology space and enhancing their impact in the healthcare industry.
Don’t miss out on this remarkable opportunity to connect with the AUA membership and promote your clinical trials to a targeted audience. Get in touch with us today to learn more about the AUA social promotion and how it can help you reach more physicians and ultimately more patients.
To improve your clinical trial recruitment efforts and increase your exposure to your target audience, it’s important to consider retargeting efforts. Retargeting from the AUA’s family of websites is a proven tool to provide maximum visibility of your programming. By using this powerful marketing tool, you can target AUA audiences based on their website visits on
AUAnet.org,
AUANews.net,
AUAUniversity, and the sites for the AUA’s scholarly publications (
The Journal of Urology®,
Urology Practice®, and
JU Open Plus) If you’re looking to reach urology patients and caregivers, we can also target your ads based on visits to specific therapeutic pages on
UrologyHealth.org.
Retargeting is a highly effective way to connect with potential participants even after they leave the AUA website. With retargeting, the AUA can microsegment audiences based on their interaction with our websites, then serve your ad to that audience on non-AUA sites. For example, if you want to target domestic urologists specializing in bladder cancer, the AUA can identify individuals who visit bladder cancer guideline pages, AUAUniversity pages on bladder cancer, or even specific bladder cancer articles in The Journal of Urology® and AUANews, then serve your ad to that audience when they visit non-AUA websites. This powerful tool increases the visibility of your ad and amplifies the number of impressions made upon those key audiences.
Studies have shown that retargeted ads have a significantly higher click-through rate (CTR) than regular display ads, with an average CTR 10 times higher. By using the power of data and the millions of data points collected by the AUA, you can expand the awareness of your clinical trials.
$20,000/100,000 Impressions
